Clinical trials by condition
Fatty liver disease (MASH/NASH) clinical trials near you
68 studies for fatty liver disease (MASH/NASH) are recruiting volunteers at 863 research sites in 39 states.
Also called Metabolic dysfunction-associated steatohepatitis (MASH), Nonalcoholic fatty liver disease (NAFLD), MASLD, Nonalcoholic steatohepatitis (NASH).
Part of Liver diseases
- Studies recruiting
- 68
- Research sites
- 863
- States
- 39
What is fatty liver disease (MASH/NASH)?
Fatty liver disease, now called steatotic liver disease, happens when too much fat builds up in the liver. Some fat in liver cells is typical, but too much can be a problem. There are two main types: one is caused by heavy alcohol use, and the other, called MASLD and formerly nonalcoholic fatty liver disease, is not.
MASLD can be simple fatty liver, with little or no inflammation or damage. When it gets worse it is called MASH, which used to be called NASH. Besides fat, MASH can cause inflammation and liver damage, leading to scarring that sometimes leads to cirrhosis or liver cancer. The cause of MASLD is unknown, but it is more common in people with type 2 diabetes, obesity or high cholesterol.
Steatotic liver disease usually causes few or no symptoms. The first step in treating MASLD is usually weight loss, which can reduce fat, inflammation and scarring in the liver. For the type caused by alcohol, the most important part of treatment is stopping drinking. When cirrhosis develops, its problems may be treated with medicines, surgery and other procedures.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus
Areas with the most fatty liver disease (MASH/NASH) studies
Metro areas where studies for fatty liver disease (MASH/NASH) are recruiting, each study counted once in an area.
By state
Studies for fatty liver disease (MASH/NASH) recruiting in each state.
- Florida29 studies · 145 sites
- California26 studies · 106 sites
- Texas25 studies · 177 sites
- Arizona21 studies · 37 sites
- New York20 studies · 28 sites
- Louisiana17 studies · 30 sites
- Ohio17 studies · 33 sites
- Virginia17 studies · 23 sites
- North Carolina16 studies · 25 sites
- Missouri15 studies · 18 sites
All 39 states
- Florida29
- California26
- Texas25
- Arizona21
- New York20
- Louisiana17
- Ohio17
- Virginia17
- North Carolina16
- Missouri15
- Tennessee12
- Arkansas11
- Indiana11
- Michigan11
- Minnesota11
- Georgia10
- Illinois10
- Massachusetts10
- Nevada10
- Maryland9
- Pennsylvania9
- Washington9
- Colorado8
- Kansas8
- New Jersey8
- South Carolina7
- Utah7
- Connecticut6
- Iowa6
- Mississippi6
- Alabama5
- Kentucky4
- Oklahoma4
- New Mexico3
- Rhode Island3
- Wisconsin2
- West Virginia2
- District of Columbia1
- South Dakota1
Whom the studies accept
The share of the fatty liver disease (MASH/NASH) studies open to each group. A study can accept several.
- Adults 18 to 6499%
- Adults 65 and over88%
- Children and teens (under 18)16%
- Healthy volunteers29%
- Open to all sexes97%
- Women only3%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Phase 17%
- Phase 1/24%
- Phase 225%
- Phase 318%
- Phase 44%
- No phase (device, behavioral and other studies)18%
- Not stated24%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Fatty liver disease (MASH/NASH) clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/fatty-liver-disease, updated November 13, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/fatty-liver-disease">LocalTrial, Fatty liver disease (MASH/NASH) clinical trials near you</a>, updated November 13, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study fatty liver disease (MASH/NASH). A study is counted once however many sites it has.
Updated November 13, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the fatty liver disease (MASH/NASH) studies near you that may fit. Free and private.
Ready to see what's near you?
Find fatty liver disease (MASH/NASH) studies near me